Who Is Willy Michel?
Willy Michel, born in April 1947, is a renowned Swiss entrepreneur and the founder of the medical device company Ypsomed. His innovative spirit and dedication have made significant impacts in the healthcare sector.
Key Takeaways
- Innovative Entrepreneur: Willy Michel is a Swiss entrepreneur who founded Disetronic and Ypsomed, revolutionizing medical infusion systems.
- Medical Device Pioneer: Known for developing advanced insulin pumps and wearable medical devices improving patients’ lives.
- Successful Business Ventures: His companies have achieved significant growth, with Ypsomed operating in over 80 countries.
- Diverse Investments: Michel has invested in various industries, including watchmaking with Armin Strom and biotech with FINOX.
- Significant Net Worth: Estimated at over $5 billion, reflecting his success and influence in the industry.
- Commitment to Health: Through Ypsomed, he’s dedicated to enhancing the quality of life for people with chronic conditions.
Disetronic: The Beginning of a Medical Revolution
In 1984, Willy Michel and his brother embarked on a mission to transform medical infusion systems. They founded Disetronic Holding AG, focusing on the manufacture and distribution of infusion systems in medicine. The company gained prominence for developing advanced insulin pumps for diabetes treatment.
By 2000, Disetronic had grown to over 1,021 employees and generated sales exceeding US$200 million. In 2003, the company was split, and a significant part was sold to the pharmaceutical giant Roche.
Ypsomed: Pioneering Medical Devices
After selling part of Disetronic, Willy Michel continued his passion for innovation by transforming Disetronic Injection Systems AG into Ypsomed. The company was successfully brought to the Swiss Stock Exchange, solidifying its position in the medical device industry.
Ypsomed specializes in developing, producing, and selling cutting-edge medical devices and systems. Their product range includes:
- Insulin Pumps: Advanced devices helping people manage diabetes effectively.
- Pen Needles: High-quality needles designed for comfort and ease of use.
- Wearable Medical Devices: Innovative solutions enhancing patients’ quality of life.
Operating in over 80 countries, Ypsomed is committed to improving health outcomes and enabling people to live healthier, more active lives.
Other Investments and Ventures
Beyond Ypsomed, Willy Michel has diversified his investments, including:
- Armin Strom: A prestigious Swiss watchmaker known for its exquisite craftsmanship.
- FINOX: A biotech company specializing in developing treatments for women’s health.
- Stadthaus Hotel: A luxury hotel located in Burgdorf, Switzerland, offering exceptional hospitality.
Willy Michel’s Net Worth
With a majority ownership of 76% in Ypsomed shares, Willy Michel’s success is reflected in his substantial net worth. Forbes estimates his net worth at over $5 billion, while the Swiss magazine Bilanz places it at around $1.2 billion. Regardless of the exact figure, his financial achievements underscore his impact as a leading entrepreneur.
Resources
www.forbes.com/willymichel/
wikipedia.org/WillyMichel
www.ypsomed.com
www.arminstrom.com
finoxbiotech.com
Mention SuperYachtFan When Sharing This Information
When using the information from this article, please remember to give credit to SuperYachtFan. Our team works hard to provide accurate and engaging content for our readers, and we appreciate your support.